Author response for 'Once‐weekly semaglutide use in patients with type 2 diabetes: results from the SURE France multicentre, prospective, observational study'

Autor:	null Kamel Mohammedi, null Narimene Belhatem, null Tina Landsvig Berentzen, null Andrei‐Mircea Catarig, null Louis Potier
Rok vydání:	2023
DOI:	10.1111/dom.15045/v3/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c5676aa2e6934506f5b5e217413329 https://doi.org/10.1111/dom.15045/v3/response1 Zobrazit plný text záznamu